About this scrapbook.

What this site is

GHK-Cu Get gathers the peer-reviewed research literature on GHK-Cu (Copper Tripeptide-1) into one place and summarizes it. It runs no clinic and keeps no clinical staff; it gives no medical advice and recommends no dose; and it makes, stocks, and sells nothing. The work is to collect the published record and report it with its citations.

The word "get" in the domain name is used as the gerund of the verb to gather — to collect clippings, to assemble a scrapbook of what is known about a molecule. The cork board, the washi tape, the polaroid plates, the sticky-note caveats, the handwritten margin notes: this is editorial vocabulary for a researcher's personal binder of the literature, not a call to acquire anything.

Editorial standards

Every quantitative claim on this site cites a real study, listed by DOI on the /references page. Where the evidence is preclinical (cell culture or rodent), the species, dose, and route are stated. Where the evidence is human, the sample size and study design are stated. Where the evidence is a Connectivity Map prediction rather than a downstream-confirmed effect, that distinction is made explicit in the body copy.

We do not invent research findings. We do not synthesize speculative dose regimens. We do not recommend self-administration of unapproved compounds. We do not link to product pages or vendor sites.

Where the literature is uncertain — for example, on the bioavailability of oral GHK-Cu in humans, on the magnitude of clinical effects predicted by transcriptomic signatures, or on the legal status of compounded injectable formulations — we say so. Uncertainty is part of the scrapbook.

About the 'get' in the domain name

A compound name paired with a short modifier is easy to misread as a service, so let this be unambiguous: 'get' here means to gather, to grasp, to collect. It does not mean to acquire, to purchase, to be supplied with, or to be prescribed. This is a publisher of editorial summaries — no retail counter, no pharmacy, no consulting room, and no commercial relationship with anyone who sells or compounds GHK-Cu.

This distinction matters because GHK-Cu is not an approved drug for any human indication, and because the regulatory status of compounded injectable GHK-Cu has been in flux since the FDA Category 2 removal in April 2026. We do not want the framing of the domain to imply otherwise.

What we are not

This is not a healthcare provider. There is no clinic location, no phone line, no clinical team — no physicians, pharmacists, nurse practitioners, or other licensed clinicians on it — and it offers no consultation, examination, prescription, diagnosis, or treatment plan.

It also makes nothing, ships nothing, imports nothing, and sells nothing, research-use or otherwise, and holds no commercial relationship with any vendor or supplier. It is no research-chemical reseller, no compounding pharmacy, no peptide vendor, no cosmetic maker, no importer.

Anything that reads like a clinical recommendation should be flagged through the contact form so the language can be revised. The intent is editorial summary only.